Results 41 to 50 of about 25,404 (153)

Worsening of renal function in patients hospitalized with acutely decompensated heart failure [PDF]

Vojnosanitetski Pregled, 2018
Background/Aim. A predictor of a poor prognosis, renal dysfunction often manifests in patients with heart failure, and is associated with an increased mortality in these patients.
Lazović Marko, Radenković Sonja, Stojanović Dijana, Radović Jelena, Stojanović Miodrag, Tasić Danijela, Stanojević Dragana   +6 more
doaj   +1 more source

Cardio-Renal Syndrome Type 4: The Correlation Between Cardiorenal Ultrasound Parameters

Kidney & Blood Pressure Research, 2016
Bakground/Aims: Cardiovascular diseases represent the leading causes of morbidity and mortality in patients with cronich kidney disease (CKD). The pathogenesis includes a complex, bidirectional interaction between heart and kidney termed cardiorenal ...
Silvia Lai, Mauro Ciccariello, Mira Dimko, Alessandro Galani, Silvio Lucci, Rosario Cianci, Amalia Mariotti   +6 more
doaj   +1 more source

Organoprotective effects of serelaxin in patients with severe decompensated heart failure

Рациональная фармакотерапия в кардиологии, 2016
Serelaxin (recombinant molecule of the human relaxin-2) is an innovative drug for the treatment of acute heart failure. Preclinical and clinical studies demonstrated the ability of serelaxin to relieve the symptoms of heart failure, provide a significant
Z. D. Kobalava, S. V. Villevalde, A. E. Solov'jova, I. A. Merai   +3 more
doaj   +1 more source

Cardio-renal-metabolic syndrome – an independent clinical picture?

Cardiologia Hungarica
Chronic kidney disease (CKD) and heart diseases (cardiovascular disease, atherosclerotic heart disease, heart failure) and metabolic diseases (metabolic syndrome [MetS], type 2 diabetes [T2DM], hyperuricemia) often occur together.
Ede Kékes
doaj   +1 more source

Role of hypoxia inducible factor pathway in cardiorenal syndrome and application prospect of HIF stabilizer

Linchuang shenzangbing zazhi, 2022
Cardiorenal syndrome （CRS） involves multiple organs. It refers to acute or chronic cardiac or renal dysfunction. Its pathophysiology involves immune inflammation，oxidative damage，anemia，iron metabolism disorders，dyslipidemia，hemodynamic disorders ...
A Rou-na, He Fang-fang, Sun Xin, Luo Chang-qing   +3 more
doaj  

Prevalence, types, risk factors, and outcomes of cardiorenal syndrome in a rural population of central India: A cross-sectional study

Journal of Family Medicine and Primary Care, 2020
Background and Objectives: Heart failure leading to renal dysfunction and vice-versa termed as Cardio-Renal Syndrome(CRS) has now been increasingly identified as a marker of higher morbidity and mortality.
Maria Prothasis, Anuj Varma, Shilpa Gaidhane, Sunil Kumar, Nazli Khatib, Quazi S Zahiruddin, Abhay Gaidhane   +6 more
doaj   +1 more source

Cardio-renal interrelation: modern view

Кардиоваскулярная терапия и профилактика, 2010
The paper discusses the definition and classification of cardio-renal syndrome (CRS) — a pathological process in heart or kidneys, characterised by acute or chronic dysfunction of one organ which results in acute or chronic failure of the other organ ...
Zh. D. Kobalava, S. V. Villewalde, M. A. Efremovtseva, V. S. Moiseev   +3 more
doaj  

Effect of Cardio-Metabolic Risk Factors Clustering with or without Arterial Hypertension on Arterial Stiffness: A Narrative Review

Diseases, 2013
The clustering of cardio-metabolic risk factors, either when called metabolic syndrome (MetS) or not, substantially increases the risk of cardiovascular disease (CVD) and causes mortality.
Vasilios G. Athyros, Andromachi Reklou, Antonis Lazarides, Eudoxia Mitsiou, Asterios Karagiannis   +4 more
doaj   +1 more source

A new insight into the treatment of renal anemia with HIF stabilizer

Renal Replacement Therapy, 2020
The long-term clinical experiences with recombinant human erythropoietin (rHuEPO) and its analog derivatives have clearly proven that correction of anemia with erythropoiesis stimulating agent (ESA) not only reduces blood transfusion and improves ...
Satoru Kuriyama, Yukio Maruyama, Hirokazu Honda   +2 more
doaj   +1 more source